Trial Identifier: | 1235-CL-0101 |
Sponsor: | Astellas Pharma Global Development, Inc. |
Start Date: | November 2016 |
Primary Completion Date: | September 2020 |
Condition: | Leukemia |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
Language | Description |
Country | Location |
---|---|
Canada, ON | Toronto, ON, Canada, M5G 2M9 |
United States of America, CA | Duarte, CA, United States of America, 91010 |
United States of America, MA | Boston, MA, United States of America, 02114 |
United States of America, MD | Baltimore, MD, United States of America, 21287 |
United States of America, NY | New York, NY, United States of America, 10016 |
United States of America, TX | Houston, TX, United States of America, 77030 |